pcDNA5/FRT/TO载体质粒图谱、序列 - 生物风

文章推薦指數: 80 %
投票人數:10人

pcDNA5/FRT/TO 载体价格6500元,pcDNA5/FRT/TO 载体质粒图谱(Vector map),载体序列(Sequence)见下文,载体质粒抗性为氨苄青霉素,质粒大小为5137bp,测序引物为CMV ... 生物风 首页 技术服务 试剂 基因・蛋白・抗体 载体 细胞 感受态・菌株 ATCC 注册 | 登录 热点推荐胎牛血清蛋白激酶生物风国际试剂进出口物流中心热点推荐Gibco胎牛血清HyClone胎牛血清Sigma胎牛血清Corning胎牛血清BI胎牛血清Gemini胎牛血清PAN胎牛血清Bovogen胎牛血清Hyclone澳洲胎牛血清Sigma澳洲小牛血清HyClone细胞培养基Gibco细胞培养基ATCC细胞培养基蛋白激酶EMSF930无血清昆虫细胞培养基生物资源载体质粒菌种库细胞库基因cDNAAdd基因感受态生物资源ATCC菌种库ATCC细胞库普通细胞株其他菌种基因cDNA质粒表达质粒Add基因质粒和载体感受态细胞大肠杆菌表达载体哺乳细胞表达载体酵母表达载体昆虫表达载体腺病毒载体慢病毒载体逆病毒载体Gateway载体植物表达载体Crispr/Cas9载体广宿主载体无细胞表达载体其他类型载体细胞培养细胞培养基血清细胞添加剂转染试剂细胞培养Gibco血清Hyclone血清Sigma血清Corning血清PAN血清BI血清Gemini血清Bovogen血清Gibco培养基HyClone培养基ATCC细胞培养基昆虫细胞培养基细胞培养添加剂DMEMRPMI-1640DMEM/F12MEMEMEMLeibovitzL-15199培养基McCoy培养基双抗/三抗PBS细胞培养级水GibcoSF900II/III昆虫培养基EMSF930昆虫无血清培养基微生物与植物培养 微生物培养基植物培养基藻类培养基抗生素添加剂微生物培养微生物培养基藻类培养基植物培养基ATCC培养基抗生素培养基添加剂植物生长素M17培养基蛋白抗体与激酶 重组蛋白激酶抗体工具酶细胞因子诊断抗原诊断抗体蛋白抗体与激酶重组蛋白重组激酶工具酶Abcam抗体Satacruz抗体诊断抗体诊断抗原细胞因子技术服务从基因到蛋白结构酶活细胞小鼠基因编辑病毒包装技术服务基因合成载体构建病毒包装蛋白表达(大肠、酵母、哺乳、昆虫、枯草)基因编辑(金葡菌、大肠、酵母、哺乳、小鼠)晶体结构RT-PCRWesternBlot细胞实验(模型建立、凋亡、粘附、划痕等)稳定细胞株构建shRNARNAi干扰免疫组化酵母双杂交酶活检测药物筛选单抗与多抗制备甲基化检测芯片课题设计与论文发表SCI与核心期刊发表文章润色文献翻译课题设计标书撰写数据统计与分析课题设计与论文发表SCI文章发表核心期刊发表母语化润色专业文献翻译开题报告指导课题设计标书写作文章图片制作数据统计与分析 pcDNA5/FRT/TO 价格:6500元 联系方式:I47-825O-882O 相关技术服务:质粒构建    基因合成    质粒大提 立刻购买 买家导航 载体基本信息 出品公司: Invitrogen 载体名称: pcDNA5/FRT/TO 质粒类型: 哺乳动物细胞表达载体;cDNA表达载体;定向重组载体;四环素调控载体 高拷贝/低拷贝: 高拷贝 克隆方法: 限制性内切酶,多克隆位点 启动子: CMVTO(CMV/TetO2) 载体大小: 5137bp 5'测序引物及序列: CMVForward:5’-CGCAAATGGGCGGTAGGCGTG-3’ 3'测序引物及序列: BGHReverse:5’-TAGAAGGCACAGTCGAGG-3’ 载体标签: 无标签 载体抗性: 氨苄青霉素 筛选标记: 潮霉素(Hygromycin) 克隆菌株: TOP10,DH5α,JM109 宿主细胞(系): Invitrogen公司出品的Flp-In细胞系,293、CV-1、CHO等 备注: pcDNA5/FRT/TO载体是cDNA的表达与克隆载体; CMVTO启动子受四环素调控; 含有FRT位点(重组酶识别位点),与pOG44载体共转染,利用重组酶进行定向重组。

产品目录号: V6520-20 稳定性: 瞬表达或稳表达 组成型/诱导型: 诱导型 病毒/非病毒: 非病毒 载体质粒图谱和多克隆位点信息 载体简介 简介 pcDNAFRTTOvectorisa5.1kbinducibleexpressionvectordesignedforusewiththeFlp-InT-RExSystem.Thecontrolplasmid,pcDNA5FRTTOCAT,isalsoincludedforuseasapositivecontrolfortransfectionandexpressioninyourFlp-InT-RExhostcelllineofchoice. pcDNA5/FRT/TOisa5.1kbinducibleexpressionvectordesignedforusewiththeFlp-InT-RExSystem(Cat.no.K6500-01)availablefromInvitrogen.WhencotransfectedwiththepOG44FlprecombinaseexpressionplasmidintoaFlp-InT-RExmammalianhostcellline,thepcDNA5/FRT/TOvectorcontainingthegeneofinterestisintegratedinaFlprecombinase-dependentmannerintothegenome.Expressionofthegeneofinterestmaybeinducedbytheadditionoftetracyclinetotheculturemedium. pcDNA5/FRT/TO载体含有以下元件: Ahybridhumancytomegalovirus(CMV)/TetO2promoterforhigh-level,tetracycline-regulatedexpressionofthegeneofinterestinawiderangeofmammaliancells(Anderssonetal.,1989;Boshartetal.,1985;HillenandBerens,1994;Hillenetal.,1983;Nelsonetal.,1987) Multiplecloningsitewith10uniquerestrictionsitestofacilitatecloningthegeneofinterest FLPRecombinationTarget(FRT)siteforFlprecombinase-mediatedintegrationofthevectorintotheFlp-InT-RExhostcellline Hygromycinresistancegeneforselectionofstablecelllines(GritzandDavies,1983) Thecontrolplasmid,pcDNA5/FRT/TO/CAT,isincludedforuseasapositivecontrolfortransfectionandexpressionintheFlp-InT-RExhostcelllineofchoice. FormoreinformationabouttheFlp-InT-RExSystem,thepOG44plasmid,andgenerationoftheFlp-InT-RExhostcellline,refertotheFlp-InT-RExCoreKitmanual. 杂交CMV/TetO2启动子 ExpressionofyourgeneofinterestfrompcDNA5/FRT/TOiscontrolledbythestrongCMVimmediateearlyenhancer/promoter(Anderssonetal.,1989;Boshartetal.,1985;Nelsonetal.,1987)intowhich2copiesofthetetoperator2(TetO2)sequencehavebeeninsertedintandem.InsertionoftheseTetO2sequencesintotheCMVpromoterconfersregulationbytetracyclinetothepromoter.TheTetO2sequencesconsistof2copiesofthe19nucleotidesequence,5′-TCCCTATCAGTGATAGAGA-3′separatedbya2basepairspacer(HillenandBerens,1994;Hillenetal.,1983).Each19nucleotideTetO2sequenceservesasthebindingsitefor2moleculesoftheTetrepressor.FormoreinformationaboutthemechanismoftetracyclineregulationintheFlp-InT-RExSystem,refertotheFlp-InT-RExCoreKitmanual. 关于pcDNA5/FRT/TO需要注意的事项 ThepcDNA5/FRT/TOvectorcontainsasingleFRTsiteimmediatelyupstreamofthehygromycinresistancegeneforFlprecombinase-mediatedintegrationandselectionofthepcDNA5/FRT/TOplasmidfollowingcotransfectionofthevector(withpOG44)intoFlp-InT-RExmammalianhostcells.TheFRTsiteservesasboththerecognitionandcleavagesitefortheFlprecombinaseandallowsrecombinationtooccurimmediatelyadjacenttothehygromycinresistancegene.TheFlprecombinaseisexpressedfromthepOG44plasmid. ThehygromycinresistancegeneinpcDNA5/FRT/TOlacksapromoterandanATGinitiationcodon;therefore,transfectionofthepcDNA5/FRT/TOplasmidaloneintomammalianhostcellswillnotconferhygromycinresistancetothecells.TheSV40promoterandATGinitiationcodonrequiredforexpressionofthehygromycinresistancegeneareintegratedintothegenome(intheFlp-InT-RExhostcellline)andareonlybroughtintothecorrectproximityandframewiththehygromycinresistancegenethroughFlprecombinase-mediatedintegrationofpcDNA5/FRT/TOattheFRTsite. Flp重组酶介导的DNA重组 IntheFlp-InT-RExSystem,integrationofyourpcDNA5/FRT/TOinducibleexpressionconstructintothegenomeoccursviaFlprecombinase-mediatedintermolecularDNArecombination.ThehallmarksofFlp-mediatedrecombinationarelistedbelow. RecombinationoccursbetweenspecificFRTsites(seebelow)ontheinteractingDNAmolecules RecombinationisconservativeandrequiresnoDNAsynthesis;theFRTsitesarepreservedfollowingrecombinationandthereisminimalopportunityforintroductionofmutationsattherecombinationsite Strandexchangerequiresonlythesmall34bpminimalFRTsite FRT位点 TheFRTsite,originallyisolatedfromSaccharomycescerevisiae,servesasabindingsiteforFlprecombinaseandhasbeenwell-characterized(GronostajskiandSadowski,1985;Jayaram,1985;Sauer,1994;Senecoffetal.,1985).TheminimalFRTsiteconsistsofa34bpsequencecontainingtwo13bpimperfectinvertedrepeatsseparatedbyan8bpspacerthatincludesanXbaIrestrictionsite.Anadditional13bprepeatisfoundinmostFRTsites,butisnotrequiredforcleavage(Andrewsetal.,1985).WhileFlprecombinasebindstoallthreeofthe13bprepeats,strandcleavageactuallyoccursattheboundariesofthe8bpspacerregion pcDNA5/FRT/TO载体使用流程如下: 载体序列 pcDNA5/FRT/TO5137bp GACGGATCGGGAGATCTCCCGATCCCCTATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTT AAGCCAGTATCTGCTCCCTGCTTGTGTGTTGGAGGTCGCTGAGTAGTGCGCGAGCAAAATTTAAGCTACA ACAAGGCAAGGCTTGACCGACAATTGCATGAAGAATCTGCTTAGGGTTAGGCGTTTTGCGCTGCTTCGCG ATGTACGGGCCAGATATACGCGTTGACATTGATTATTGACTAGTTATTAATAGTAATCAATTACGGGGTC ATTAGTTCATAGCCCATATATGGAGTTCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCG CCCAACGACCCCCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACTTTCC ATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTACATCAAGTGTATCATATGCC AAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTATGCCCAGTACATGACCTTA TGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGC AGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACGTCAA TGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACG CAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCTCCCTATCAGTGATAGAGATC TCCCTATCAGTGATAGAGATCGTCGACGAGCTCGTTTAGTGAACCGTCAGATCGCCTGGAGACGCCATCC ACGCTGTTTTGACCTCCATAGAAGACACCGGGACCGATCCAGCCTCCGGACTCTAGCGTTTAAACTTAAG CTTGGTACCGAGCTCGGATCCACTAGTCCAGTGTGGTGGAATTCTGCAGATATCCAGCACAGTGGCGGCC GCTCGAGTCTAGAGGGCCCGTTTAAACCCGCTGATCAGCCTCGACTGTGCCTTCTAGTTGCCAGCCATCT GTTGTTTGCCCCTCCCCCGTGCCTTCCTTGACCCTGGAAGGTGCCACTCCCACTGTCCTTTCCTAATAAA ATGAGGAAATTGCATCGCATTGTCTGAGTAGGTGTCATTCTATTCTGGGGGGTGGGGTGGGGCAGGACAG CAAGGGGGAGGATTGGGAAGACAATAGCAGGCATGCTGGGGATGCGGTGGGCTCTATGGCTTCTGAGGCG GAAAGAACCAGCTGGGGCTCTAGGGGGTATCCCCACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTG TGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCC TTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGA TTTAGTGCTTTACGGCACCTCGACCCCAAAAAACTTGATTAGGGTGATGGTTCACGTACCTAGAAGTTCC TATTCCGAAGTTCCTATTCTCTAGAAAGTATAGGAACTTCCTTGGCCAAAAAGCCTGAACTCACCGCGAC GTCTGTCGAGAAGTTTCTGATCGAAAAGTTCGACAGCGTCTCCGACCTGATGCAGCTCTCGGAGGGCGAA GAATCTCGTGCTTTCAGCTTCGATGTAGGAGGGCGTGGATATGTCCTGCGGGTAAATAGCTGCGCCGATG GTTTCTACAAAGATCGTTATGTTTATCGGCACTTTGCATCGGCCGCGCTCCCGATTCCGGAAGTGCTTGA CATTGGGGAATTCAGCGAGAGCCTGACCTATTGCATCTCCCGCCGTGCACAGGGTGTCACGTTGCAAGAC CTGCCTGAAACCGAACTGCCCGCTGTTCTGCAGCCGGTCGCGGAGGCCATGGATGCGATCGCTGCGGCCG ATCTTAGCCAGACGAGCGGGTTCGGCCCATTCGGACCGCAAGGAATCGGTCAATACACTACATGGCGTGA TTTCATATGCGCGATTGCTGATCCCCATGTGTATCACTGGCAAACTGTGATGGACGACACCGTCAGTGCG TCCGTCGCGCAGGCTCTCGATGAGCTGATGCTTTGGGCCGAGGACTGCCCCGAAGTCCGGCACCTCGTGC ACGCGGATTTCGGCTCCAACAATGTCCTGACGGACAATGGCCGCATAACAGCGGTCATTGACTGGAGCGA GGCGATGTTCGGGGATTCCCAATACGAGGTCGCCAACATCTTCTTCTGGAGGCCGTGGTTGGCTTGTATG GAGCAGCAGACGCGCTACTTCGAGCGGAGGCATCCGGAGCTTGCAGGATCGCCGCGGCTCCGGGCGTATA TGCTCCGCATTGGTCTTGACCAACTCTATCAGAGCTTGGTTGACGGCAATTTCGATGATGCAGCTTGGGC GCAGGGTCGATGCGACGCAATCGTCCGATCCGGAGCCGGGACTGTCGGGCGTACACAAATCGCCCGCAGA AGCGCGGCCGTCTGGACCGATGGCTGTGTAGAAGTACTCGCCGATAGTGGAAACCGACGCCCCAGCACTC GTCCGAGGGCAAAGGAATAGCACGTACTACGAGATTTCGATTCCACCGCCGCCTTCTATGAAAGGTTGGG CTTCGGAATCGTTTTCCGGGACGCCGGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTC GCCCACCCCAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAA ATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTG TATACCGTCGACCTCTAGCTAGAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTAT CCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGA GCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCA TTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCCGCTTCCTCGCTCACT GACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTAT CCACAGAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAA AAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACGAGCATCACAAAAATCGACGCTCA AGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGC GCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCT TTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCAC GAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGAC ACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTAC AGAGTTCTTGAAGTGGTGGCCTAACTACGGCTACACTAGAAGAACAGTATTTGGTATCTGCGCTCTGCTG AAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTAGCGGTG GTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTC TACGGGGTCTGACGCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGG ATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTT GGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCAT AGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCA ATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCG AGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGT AAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCG TCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGT GCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACT CATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGT GAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATAC GGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAA ACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCA GCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAA TAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTGAAGCATTTATCAGGG TTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACA TTTCCCCGAAAAGTGCCACCTGACGTC 载体质粒图谱pdf版和相关资料下载 载体应用举例 pcDNA5/FRT/TO-TOPO2015-04-26 上一篇:pcDNA5/FRT 下一篇:pcDNA5/TO 分享到: 推荐 7 全部载体分类 大肠杆菌表达载体哺乳动物表达载体 酵母表达载体 昆虫表达载体 腺病毒载体 慢病毒载体 逆病毒载体 Gateway载体 植物表达载体 CRISPR/Cas9载体 广宿主载体 其他类型载体 相关载体 pHL1 pGreenII0800-LUC pGL4.32[luc2P/NF-κB-RE/Hygro] pUC57-Tac-mCherry pJP3 pcDNA3.1+P2A pAYC32 pCJ105 pZL205 pMBP-Bgl22-2 pLY101 PinPointXa-2 pSRE-Luc pQCXIN pTi pJC74 pcDNA3.1+C-eGFP pGL101 pTALETF_v2(NG) pSicoR pkk223-3 pGWB4 pDM2 pETBlue-2 pIEx/Bac-3 pBAD102/D-TOPO pSP65-F1+ R6K pSwitch pEGFP-N3 pTALEN_v2(NN) pAAV-tTS-shRNA gRNA_CloningVector p10A1 CAM pTransketo-TA pKEX4tr pRB395 pCFB pPink-LC pAsRed2-N1 pCMV-BD RK2 pCMV-MCS pYC121 pNL3.3[secNluc/minP] pLenti6/UbC-V5-DEST pET-43.1EK/LIC pLVX-TRE3G-ZsGreen1 pcDNA3.1/Myc-HisA pZL207 pCS105 pQE-81L AAV-CAGGS-EGFP pNL2.1[Nluc/Hygro] pcDNA5/FRT/TO-TOPO Yp14g pRS425 pBad/gIIIA pRSVADH pILJ16 pBABE-PuroSV40LT pDsRed2-Bid pRS415 pYES2-kan pEZZ18 pRS41H pET-28a-EGFP pMXs-miR-GFP-Puro pLVX-DD-AmCyan1Reporter pPIC9K pAAV-CA pFUSE-hIgG1e1-Fc2 pL-CRISPR.EFS.GFP pBABE-neo pDR540 pLVX-tdTomato-C1 pPIC6B pEF1/myc-HisB pDEST22 pLenti6.3-MCS-IRES2-DsRed2 pUC12 pMSCVpuro pVPack-GP pLVX-mCMV-ZsGreen1-Puro pET-24d(+) pZsGreen1-DR pBeloBAC11 pUCD1752 pTALEN_v2(NI) pGBKT7 pGL4.52[luc2P/STAT5RE/Hygro] pRetroX-PTuner2-C pP53-208 pCX-DG pBV220 pET-50b(+) pNL1.3[secNluc] pTrcHis2A pMetLuc2-Reporter pET28a-TEV pCMV6-AC-IRES-GFP pYC50 pET-11a(+) pCS2- pLVX-DD-ZsGreen1Control pEF6/V5-HisTOPOTA pEMBLYe23 pKT240 pGEM-T pcDNA3.1-Cre pGluconateKinase_TA pcDNA3.1/nV5-DEST pPIC6A pGL4.74[hRluc/TK] pRSVneo pBLADE-SX pEarleyGate203 pPICZαFC pLVX-Hom-Nuc1 pDrive pGL4.82[hRluc/Puro] pKD46 pUC4-KISS pPZP102 pGEX-3X pAcGFP1-Mito pET-19b pNTAP-Shuttle-B pSFV1 pcDNA3.1+/N-GST(TEV) pFastBac1-GST-N pLeu-mesen0927GH1_MBP pmCherry-C1 pNuc1 pMH621 pCDNA3.1-3×HA-N pBR322 pRI101-ON pESP-3 pLVX-ZsGreen-miRNA-Puro pCR9-10 pRS315 pHM12 pGL4.77[hRlucP/Hygro] pRSVZ psfGFP pCA1 LeGO-iC2 pIRESneo pNTAP-Shuttle-A pDEST27 pAN26 pBridge pRI101-AN pRB15(YEp6) ppArt.chl-bgl1-483 pMal-c5E pECFP-Peroxi pCMV-RFP-C-Myc 相关文章 pcDNA5/FRT/TO-TOPO 相关问答 pcDNA5/FRT/TO-TOPO 关于我们 加入生物风 网站地图 Sitemap Copyright©20012-2013BIOFENG.生物风版权所有PoweredbyBiofeng沪ICP备2021037978号-1



請為這篇文章評分?